fMRI of Hypothalamic Responses to Taste, Temperature and Glucose

N/ACompletedNCT03202342

Unilever R&D16 enrolled

Overview

The study will consist of five occasions with one week in between. BOLD signal intensity of the hypothalamus will be measured using fMRI. Measurements will be done before and after drinking 300 ml plain water or water to which glucose and/or ethyl butyrate will be added.

The hypothalamus is known to be important for control of feeding behaviour as well as the regulation of temperature. Functional magnetic resonance imaging (fMRI) is a non-invasive method, which detects transient haemodynamic changes in the brain, using blood oxygen level dependent (BOLD) signal differences. In order to investigate the role of hypothalamic neural activity in response to taste, glucose and temperature, fMRI will be performed before, during and after ingestion of 300 ml plain water or water with added ethyl butyrate (pineapple flavour), added glucose or added ethyl butyrate plus glucose. All beverages will be consumed at 22 °C and the combination will also be drunk at 0 °C. The study uses a randomised cross-over design in 16 healthy male subjects with a normal body weight. There will be an interval of at least one week between the five occasions. BOLD signal intensity of the hypothalamus will be continuously measured for 21 minutes (5 minutes baseline, 4 minutes during drinking and 12 minutes after drinking).

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

BASIC_SCIENCE

Masking

NONE

Enrollment

Conditions

Healthy

Interventions

WaterOTHER

Water, 300 ml, at room temperature

GlucoseOTHER

Water containing 50 g glucose, 300 ml, at room temperature

Ethyl butyrateOTHER

Water containing ethyl butyrate (pineapple flavour) 300 ml, at room temperature

Eligibility

Sex: MALEMin age: 18 YearsMax age: 25 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Signed informed consent * Age between 18 and 25 years * BMI between 20 and 23 kg/m2 * Length between 170 and 190 centimetres Exclusion Criteria: * Diabetes or history of other disturbances of glucose metabolism (eg impaired glucose tolerance, hypoglycaemia). * Any genetic or psychiatric disease (e.g. fragile X syndrome, major depression) affecting brain * Any significant chronic disease * Renal or hepatic disease * Recent weight changes or attempts to lose weight (\> 3 kg weight gain or loss, within the last 3 months) * Smoking (current or last 6 months) * Alcohol consumption of more than 21 units per week or use of recreational drugs at present or in the last year * Recent blood donation (within the last 2 months) * Recent participation in other biomedical research projects (within the last 3 months), participation in 3 or more biomedical research projects in one year * Contra-indication to MRI scanning: * Claustrophobia * Pacemakers and defibrillators * Nerve stimulators * Intracranial clips * Intraorbital or intraocular metallic fragments * Cochlear implants * Ferromagnetic implants

Locations (1)

Leids Universitair Medisch Centrum

Leiden, South Holland, Netherlands

Outcomes

Primary Outcomes

Determine hypothalamic function in response to taste, temperature and glucose sensing

BOLD-signal intensity

Time frame: Before (5 minutes) and after (12 minutes) drinking

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.